Realcan Pharmaceutical Group Co., Ltd.

SZSE:002589.SZ

3.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 31.971-1,739.473382.013624.552-434.981,277.8061,368.456675.074243.134181.761144.242110.66984.02362.13244.8129.178
Depreciation & Amortization 219.681283.882319.217289.342274.821234.342146.93578.72443.12324.49211.8037.8976.2124.5913.6762.843
Deferred Income Tax -170.863-101.579-177.448-59.92638.136142.42339.363-22.012-11.3330000000
Stock Based Compensation 19.299000000000000000
Change In Working Capital -432.75136.718-966.665-1,161.424-14.797-2,450.267-4,011.303-2,700.461-868.979-453.126-502.779-347.287-593.475-14.392-0.689-92.172
Accounts Receivables 1,121.886-6,339.976-197.205-198.131-979.798-5,342.874-2,766.94-1,858.376-1,537.342-946.019-652.524-628.9420000
Inventory -165.263190.719476.903377.985525.158-276.018-1,339.76-318.93-314.823-197.228-85.357-84.846-103.987-66.035-16.633-60.661
Accounts Payables -1,218.5116,387.553-1,068.915-1,253.58401.7063,004.48856.035-501.142994.5180000000
Other Working Capital -1,389.373-101.579-177.448-87.69838.136-2,174.248-2,671.543-2,381.531-554.156-255.898-417.422-262.441-489.48851.64415.943-31.511
Other Non Cash Items 329.4521,841.947708.388612.072,269.481768.70473.999187.618116.46183.25272.27558.228.20918.22613.58810.276
Operating Cash Flow 82.467523.074442.953364.5392,094.525-169.415-2,421.912-1,759.046-466.262-163.621-274.459-170.52-475.03270.55761.385-49.876
Investing Activities:
Investments In Property Plant And Equipment -298.384-170.964-461.086-505.393-934.871-604.316-385.199-317.303-109.466-183.25-153.098-112.249-28.597-37.72-19.231-30.958
Acquisitions Net 1,164.541,033.638.679-116.248-146.144-800.95-471.578-324.41-279.839-26.018-18.006-1.078-16.8440-1.91730.958
Purchases Of Investments -296.822-273.33-49.5-410.081-199-84.6-2.058-3.218-1,421.57-1,525.0850-4.010-0.2810-12.504
Sales Maturities Of Investments 11.14132.76521.17128.85811.7340.364.5160.1611,401.1511,526.1560112.29900012.594
Other Investing Activites -1.652-29.144-102.77758.828-50.344-89.9981.5586.1349.416.3430.227-112.2490.0590.0220.254-30.958
Investing Cash Flow 579.53592.957-583.513-944.037-1,318.626-1,579.497-772.761-638.635-400.315-201.853-170.877-117.288-45.381-37.979-20.895-30.868
Financing Activities:
Debt Repayment -1,431.927-4,339.459-6,813.435-9,783.194-17,805.784-15,111.697-5,975.169-3,259.961-2,420.097-1,934.521-1,120.572-706.164-587.995-439.05-325-205
Common Stock Issued 029.5774.48.0372.3400000000000
Common Stock Repurchased -28.54-29.577-4.4-8.03-72.3400000000000
Dividends Paid -201.694-13.269-26.375-346.562-77.815-516.059-224.327-114.309-93.252-83.19-70.576-44.06-18.962-12.066-9.37-5.919
Other Financing Activities -1,827.2843,028.6487,079.3319,065.33118,037.42617,898.1039,155.9736,606.8573,858.8732,295.171,939.0861,138.8961,148.83483.433397.328299.894
Financing Cash Flow -677.197-1,465.125-50.416-1,055.054-267.9992,270.3472,956.4773,232.5871,345.524277.459747.937388.672541.87432.31762.95888.975
Other Information:
Effect Of Forex Changes On Cash -0.0010.004-0.0020.002-00.1530-00-00-0-0-00-0
Net Change In Cash -15.201-349.09-190.978-1,634.55507.9521.588-238.196834.907478.948-88.016302.601100.86421.4664.895103.4488.232
Cash At End Of Period 471.942487.143836.2331,007.5122,642.0622,133.8221,612.2341,850.431,015.523536.576624.591321.991221.127199.667134.77131.324